6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Ịdị Ọcha ≥98.0% (HPLC) Favipiravir Intermediate COVID-19
Onye nrụpụta nwere ịdị ọcha dị elu yana ogo kwụsiri ike
Nbunye azụmaahịa Favipiravir na ihe ndị metụtara ya:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Aha Chemical | 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile |
Ụdị okwu | 6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile |
Nọmba CAS | 356783-31-8 |
Nọmba CAT | RF-API294 |
Ọnọdụ Ahịa | Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms |
Usoro ihe omimi | C5H2FN3O |
Ibu molekụla | 139.09 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Icha odo odo ka ọ bụrụ ntụ ntụ na-acha ọcha |
njirimara | IR, HPLC |
Mmiri (KF) | ≤1.0% |
Ihe fọdụrụ na mgbanye | ≤0.50% |
Otu adịghị ọcha | ≤1.0% |
Mgbakọta adịghị ọcha | ≤2.0% |
Ọla dị arọ | ≤20ppm |
Ịdị ọcha | ≥98.0% (nke HPLC) |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke Favipiravir (CAS 259793-96-9);Antiviral;COVID 19 |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) bụ etiti nke Favipiravir (CAS 259793-96-9).Favipiravir bụ ọgwụ mgbochi ọhụụ sara mbara nke na-eche RNA polymerase (RdRp) dabere na RNA.Emebere Favipiravir na ngwụcha 1990s site na ụlọ ọrụ nke ụlọ ọrụ Japan bụ Fujifilm zụtara ya dịka akụkụ nke mgbanwe ya site na azụmaahịa foto gaa na ahụike.Mgbe a nwalechara ya megide nje dị iche iche, a kwadoro ọgwụ ahụ na Japan na 2014 maka iji ihe mberede mee ihe megide ọrịa na-efe efe ma ọ bụ ịgwọ ụdị influenza ọhụrụ.N'oge ntiwapụ nke coronavirus ọhụrụ, nsonaazụ nke usoro ọmụmụ ụlọ ọgwụ nke Phase I nke e bipụtara na Machị 2020 gosiri na ọgwụ ahụ nwere ike inwe mmetụta nke ime ka mkpochapụ nje dị ngwa iji belata ọganihu nke oyi oyi ọhụrụ coronavirus.Enwere ike iji Favipiravir na ọgwụgwọ ndị ọrịa nwere COVID-19 nke WHO kwadoro.Onye na-ahụ maka ọgwụ na India (DCGI) kpochapụrụ ya maka iji “mmachibidoro ihe mberede” n'etiti ndị ọrịa COVID-19.